presence of concomitant CIS, and muscle in the specimen were analysed in order to evaluate risk factors of residual disease at re-TUR, both in univariate analyses and multivariate logistic regressions.
INTRODUCTION AND OBJECTIVES: Transurethral resection (TUR) is standard therapy for non-muscle invasive bladder cancer (NMIBC). Radical resection is an important predictor for outcome, and accurate pathological diagnosis is the key determinant factor to decide treatment strategy after TUR. In short, TUR are expected to complete excision and accurate pathological diagnosis for improved the prognosis in patients with NMIBC. Although TUR methods are established, pathological diagnosis is difficult because of heat denaturation and burn mark. In recent years, transurethral En-bloc resection technique is reported to be useful for judging cancer invasion in NMIBC. However, such method has disadvantage in prolongation of surgical time, particularly in large tumors. In this study, we investigated the usefulness and safety of combination therapy of electrical En-bloc resection and endoscopic mucosal resection (En-bloc + EMR) in NMIBC patients. METHODS: We analyzed 30 patients who were clinically diagnosed with NMIBC. The median of the tumour diameter was 30 (15e55) mm. At first, a tumour mass was cut by using CAPTIVATOR II (Boston Scientific) in the same way as EMR. Subsequently, a circular incision was created around the residual tumour, maintaining a distance of approximately 5e10 mm from the tumour edge, for the En-bloc resection. For the control, TUR was performed in 16 patients that were matched for tumour diameter and clinical stage. All surgeries were performed by one urologist. Before the patients were enrolled, the institutional ethical committee approved the study, and written informed consent was obtained. RESULTS: The mean operation time for EMR and En-bloc resection was 1.2 and 13.9 min respectively and total operation time was 15.0 min. That was similar to that for TUR (P ¼ 0.94, mean ¼ 16.2 and SD ¼ 3.8 min). One patients had mild perforation of the bladder. However, no severe complications were observed and no significant difference was found regarding periods of catheterization and hospitalization. The pathologists can diagnose the invasion status with considerable certainty in all specimens obtained by En-bloc + EMR, compared to by TUR because of less heat denaturation and burn mark.
CONCLUSIONS: Our results showed En-bloc + EMR technique is a useful and safe. We believe that this technique is particularly suitable for large tumors because control of bleeding and visual field are clearly better than TUR. In addition, this technique has an advantage in accurate pathological diagnosis to distinguish pTa and pT1.
Source of Funding: None. METHODS: We included 601 patients with primary (first tumor) T1-BC, who were treated with at least one induction schedule of BCG instillations and followed in four university hospitals. The slides were reviewed by 3 uro-pathologists and sub-staged according to two classifications: Metric sub-stage according to T1micro-invasive (T1mlamina propria invasion <0.5mm) vs. T1extensive-invasive (T1e -invasion 0.5mm) and secondly, according to presence or absence of muscularis mucosae invasion (MM -T1a vs. T1b). Prognostic value for progression-free survival (PFS) and cancer-specific survival (CSS) were analyzed for each system with a multivariable step-wise coxregression model. We corrected for sex, age, size (>3cm vs. 3 cm), concomitant CIS, WHO 1973 and WHO 2004 grade. RESULTS: Median follow-up was 5.9 (IQR 3.3-9.0) years. Median age was 71 (IQR 15) years, 150 (25%) patients were female. Concomitant CIS was found in 196 (33%) cases. Metric sub-staging was possible in all cases. T1m was found in 213 (35%) tumors vs. 388 (65%) T1e. Based on MM invasion, 281 (47%) tumours were staged T1a vs. 320 (53%) T1b. MM was identified at the invasion front in 466 (78%) tumors. During follow-up, progression (cT2 and/or N1 and/or M1) was found in 148 (25%) patients and 95 (16%) patients died of BC. On univariable analysis, both sub-staging systems were significantly associated with PFS and CSS. On multivariable analysis, metric (T1m/ e) sub-stage (T1e vs. T1m; HR 3.8, 95%CI 2.3-6.0, p<0.001) and WHO 1973 grade (G3 vs. G2; HR 1.8, 95%CI 1.2-2.7, p¼0.006) were prognostic for progression. Independently associated with worse CSS were T1e (HR 2.7, 95%CI 1.6-4.8), WHO 1973 G3 (HR 2.6, 95%CI 1.4-4.7, p¼0 .002), increasing age (HR 1.03, 95%CI 1.01-1.05, p¼0.002) and tumor size >3 cm (HR 1.8, 95%CI 1.2-2.9, p¼0.008).
CONCLUSIONS: In this multi-center study, metric (T1m/e) substage proved a very reliable and strong prognosticator for progression and cancer-specific survival. Our results suggest that metric T1 substage may aid in treatment decision-making between conservative treatment and radical cystectomy for clinical T1-BC. T1a/b sub-stage has inferior prognostic value and reproducibility. Ultimately, metric substage (T1m/e) may be incorporated in the TNM classification system for urinary BC. . 197, No. 4S, Supplement, Sunday, May 14, 2017 
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